“Glioma surgery entails sculpting out a tumor that truly cannot be seen because of the surrounding fog and its relative positioning to the brain,” explains Yaron A. Moshel, MD, PhD, Co-Director of the Gerald J. Glasser Brain Tumor Center and a neurosurgeon with Altair Health. “When these dense tumors infiltrate the body’s most complicated organ, the brain, and become intertwined with the functional areas that control language, memory, motor and sensory skills – as they often do – the risks and challenges of removing them intensify.”
Removing gliomas as safely and completely as possible requires years of experience and a deep understanding of the brain’s three-dimensional anatomy and functional relationships. Today, this expertise is supported by technological advances that enable more precise, less-invasive tumor removal.
From 2D to 3D with Stereotactic Guidance
Traditionally, neurosurgeons used two-dimensional MRI scans taken before surgery to help them envision the tumor and guide their approach in the operating room. Now, with Medtronic’s Stealth Station S8 Surgical Navigation System – the most advanced stereotactic guidance available – multiple types of MRI scans, including functional scans that illuminate speech and motor centers, can be overlaid with three-dimensional images of the tumor. This imaging and GPS-like technology help identify the tumor’s boundaries and provide a precise surgical line of sight.
“The move from 2D to 3D is significant,” adds Dr. Fabio Frisoli, MD, a neurosurgeon at Glasser and Altair Health. “With a 3D view of the tumor, you’re much more likely to be able to remove the tumor in its entirety while minimizing any potential disturbance to other areas of the brain.”
Fluorescent Imaging, Glowing Tumors and the Standard of Care for the Future
Fluorescent imaging is one of the newest advancements in brain tumor care. Patients ingest 5 ALA, a liquid solution that circulates throughout the body and causes a malignant tumor to glow a bright orange color. The tumor fluorescence is seen with a special microscope equipped with a highly specific blue light filter. After years of use abroad, this emergent technology was recently approved for use in the U.S.
“Glasser is one of the first providers in New Jersey to harness the power of fluorescent imaging for brain tumor care. We believe this fluorescent tracer will become the standard of care because of the immense advantage it provides in distinguishing malignant cells from healthy tissue,” says Dr. Moshel.
Combining Technologies with Advanced Microscopes
The newest microscope, the Zeiss Kinevo, incorporates intraoperative fluorescent imaging of the tumor and the Stealth Navigation 3D images, giving neurosurgeons every piece of information they need during surgery, including a “heads-up display.”
“Before this technology, neurosurgeons would essentially look at a screen on their left displaying an MRI, then turn back to the operating table to apply what they saw on screen to the patient in front of them,” explains Dr. Moshel. “This combination of technologies now allows us to see everything right in front of us and safely remove some of the most complex tumors in some of the most difficult-to-reach locations.”
“Coming to battle with leading-edge technology and advanced tools continues to change the landscape of what’s possible with brain tumor surgery. These advances play a significant role in achieving enhanced outcomes and improved long-term prognoses,” Dr. Frisoli concludes.